TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Human Microbiome Based Drugs And Diagnostics Market - By Product
1.3.2 Human Microbiome Based Drugs And Diagnostics Market - By Application
1.3.3 Human Microbiome Based Drugs And Diagnostics Market - By Disease
1.3.4 Human Microbiome Based Drugs And Diagnostics Market - By Research Spending, product Type
1.3.5 Human Microbiome Based Drugs And Diagnostics Market - By Research spending, Technology Type
1.3.6 Human Microbiome Based Drugs And Diagnostics Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. FOOD, PROBIOTICS, PREBIOTICS, MEDICAL FOOD, DIAGNOSTIC DEVICES, DRUGS, OTHER PROBIOTIC SUPPLEMENTS
7.3.1. Overview
7.3.2. Food, Probiotics, Prebiotics, Medical Food, Diagnostic Devices, Drugs, Other Probiotic Supplements Market Forecast and Analysis
8. HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. THERAPEUTICS, DIAGNNOSTICS
8.3.1. Overview
8.3.2. Therapeutics, Diagnnostics Market Forecast and Analysis
9. HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE
9.1. OVERVIEW
9.2. DISEASE MARKET FORECASTS AND ANALYSIS
9.3. ACUTE DIARRHEA, OBESITY, DIABETES, AUTOIMMUNE DISORDERS, CANCER, MENTAL DISORDERS, OTHER DISEASES
9.3.1. Overview
9.3.2. Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, Other Diseases Market Forecast and Analysis
10. HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - RESEARCH SPENDING, PRODUCT TYPE
10.1. OVERVIEW
10.2. RESEARCH SPENDING, PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
10.3. INSTRUMENTS
10.3.1. Overview
10.3.2. Instruments Market Forecast and Analysis
10.3.3. Laboratory Instruments Market
10.3.3.1. Overview
10.3.3.2. Laboratory Instruments Market Forecast and Analysis
10.3.4. Analyzers Market
10.3.4.1. Overview
10.3.4.2. Analyzers Market Forecast and Analysis
10.4. CONSUMABLES
10.4.1. Overview
10.4.2. Consumables Market Forecast and Analysis
10.4.3. Kits Market
10.4.3.1. Overview
10.4.3.2. Kits Market Forecast and Analysis
10.4.4. Reagents Market
10.4.4.1. Overview
10.4.4.2. Reagents Market Forecast and Analysis
11. HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - RESEARCH SPENDING, TECHNOLOGY TYPE
11.1. OVERVIEW
11.2. RESEARCH SPENDING, TECHNOLOGY TYPE MARKET FORECASTS AND ANALYSIS
11.3. CELL CULTURE TECHNOLOGY, HIGH THROUGHPUT TECHNOLOGY, OMICS TECHNOLOGY
11.3.1. Overview
11.3.2. Cell Culture Technology, High Throughput Technology, Omics Technology Market Forecast and Analysis
12. HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Human Microbiome Based Drugs And Diagnostics Market Overview
12.1.2 North America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis
12.1.3 North America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Product
12.1.4 North America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Application
12.1.5 North America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Disease
12.1.6 North America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Research Spending, product Type
12.1.7 North America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Research spending, Technology Type
12.1.8 North America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Countries
12.1.8.1 United States Human Microbiome Based Drugs And Diagnostics Market
12.1.8.1.1 United States Human Microbiome Based Drugs And Diagnostics Market by Product
12.1.8.1.2 United States Human Microbiome Based Drugs And Diagnostics Market by Application
12.1.8.1.3 United States Human Microbiome Based Drugs And Diagnostics Market by Disease
12.1.8.1.4 United States Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.1.8.1.5 United States Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.1.8.2 Canada Human Microbiome Based Drugs And Diagnostics Market
12.1.8.2.1 Canada Human Microbiome Based Drugs And Diagnostics Market by Product
12.1.8.2.2 Canada Human Microbiome Based Drugs And Diagnostics Market by Application
12.1.8.2.3 Canada Human Microbiome Based Drugs And Diagnostics Market by Disease
12.1.8.2.4 Canada Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.1.8.2.5 Canada Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.1.8.3 Mexico Human Microbiome Based Drugs And Diagnostics Market
12.1.8.3.1 Mexico Human Microbiome Based Drugs And Diagnostics Market by Product
12.1.8.3.2 Mexico Human Microbiome Based Drugs And Diagnostics Market by Application
12.1.8.3.3 Mexico Human Microbiome Based Drugs And Diagnostics Market by Disease
12.1.8.3.4 Mexico Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.1.8.3.5 Mexico Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.2. EUROPE
12.2.1 Europe Human Microbiome Based Drugs And Diagnostics Market Overview
12.2.2 Europe Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis
12.2.3 Europe Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Product
12.2.4 Europe Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Application
12.2.5 Europe Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Disease
12.2.6 Europe Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Research Spending, product Type
12.2.7 Europe Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Research spending, Technology Type
12.2.8 Europe Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Human Microbiome Based Drugs And Diagnostics Market
12.2.8.1.1 Germany Human Microbiome Based Drugs And Diagnostics Market by Product
12.2.8.1.2 Germany Human Microbiome Based Drugs And Diagnostics Market by Application
12.2.8.1.3 Germany Human Microbiome Based Drugs And Diagnostics Market by Disease
12.2.8.1.4 Germany Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.2.8.1.5 Germany Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.2.8.2 France Human Microbiome Based Drugs And Diagnostics Market
12.2.8.2.1 France Human Microbiome Based Drugs And Diagnostics Market by Product
12.2.8.2.2 France Human Microbiome Based Drugs And Diagnostics Market by Application
12.2.8.2.3 France Human Microbiome Based Drugs And Diagnostics Market by Disease
12.2.8.2.4 France Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.2.8.2.5 France Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.2.8.3 Italy Human Microbiome Based Drugs And Diagnostics Market
12.2.8.3.1 Italy Human Microbiome Based Drugs And Diagnostics Market by Product
12.2.8.3.2 Italy Human Microbiome Based Drugs And Diagnostics Market by Application
12.2.8.3.3 Italy Human Microbiome Based Drugs And Diagnostics Market by Disease
12.2.8.3.4 Italy Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.2.8.3.5 Italy Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.2.8.4 Spain Human Microbiome Based Drugs And Diagnostics Market
12.2.8.4.1 Spain Human Microbiome Based Drugs And Diagnostics Market by Product
12.2.8.4.2 Spain Human Microbiome Based Drugs And Diagnostics Market by Application
12.2.8.4.3 Spain Human Microbiome Based Drugs And Diagnostics Market by Disease
12.2.8.4.4 Spain Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.2.8.4.5 Spain Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.2.8.5 United Kingdom Human Microbiome Based Drugs And Diagnostics Market
12.2.8.5.1 United Kingdom Human Microbiome Based Drugs And Diagnostics Market by Product
12.2.8.5.2 United Kingdom Human Microbiome Based Drugs And Diagnostics Market by Application
12.2.8.5.3 United Kingdom Human Microbiome Based Drugs And Diagnostics Market by Disease
12.2.8.5.4 United Kingdom Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.2.8.5.5 United Kingdom Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.2.8.6 Rest of Europe Human Microbiome Based Drugs And Diagnostics Market
12.2.8.6.1 Rest of Europe Human Microbiome Based Drugs And Diagnostics Market by Product
12.2.8.6.2 Rest of Europe Human Microbiome Based Drugs And Diagnostics Market by Application
12.2.8.6.3 Rest of Europe Human Microbiome Based Drugs And Diagnostics Market by Disease
12.2.8.6.4 Rest of Europe Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.2.8.6.5 Rest of Europe Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market Overview
12.3.2 Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis
12.3.3 Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Product
12.3.4 Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Application
12.3.5 Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Disease
12.3.6 Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Research Spending, product Type
12.3.7 Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Research spending, Technology Type
12.3.8 Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Human Microbiome Based Drugs And Diagnostics Market
12.3.8.1.1 Australia Human Microbiome Based Drugs And Diagnostics Market by Product
12.3.8.1.2 Australia Human Microbiome Based Drugs And Diagnostics Market by Application
12.3.8.1.3 Australia Human Microbiome Based Drugs And Diagnostics Market by Disease
12.3.8.1.4 Australia Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.3.8.1.5 Australia Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.3.8.2 China Human Microbiome Based Drugs And Diagnostics Market
12.3.8.2.1 China Human Microbiome Based Drugs And Diagnostics Market by Product
12.3.8.2.2 China Human Microbiome Based Drugs And Diagnostics Market by Application
12.3.8.2.3 China Human Microbiome Based Drugs And Diagnostics Market by Disease
12.3.8.2.4 China Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.3.8.2.5 China Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.3.8.3 India Human Microbiome Based Drugs And Diagnostics Market
12.3.8.3.1 India Human Microbiome Based Drugs And Diagnostics Market by Product
12.3.8.3.2 India Human Microbiome Based Drugs And Diagnostics Market by Application
12.3.8.3.3 India Human Microbiome Based Drugs And Diagnostics Market by Disease
12.3.8.3.4 India Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.3.8.3.5 India Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.3.8.4 Japan Human Microbiome Based Drugs And Diagnostics Market
12.3.8.4.1 Japan Human Microbiome Based Drugs And Diagnostics Market by Product
12.3.8.4.2 Japan Human Microbiome Based Drugs And Diagnostics Market by Application
12.3.8.4.3 Japan Human Microbiome Based Drugs And Diagnostics Market by Disease
12.3.8.4.4 Japan Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.3.8.4.5 Japan Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.3.8.5 South Korea Human Microbiome Based Drugs And Diagnostics Market
12.3.8.5.1 South Korea Human Microbiome Based Drugs And Diagnostics Market by Product
12.3.8.5.2 South Korea Human Microbiome Based Drugs And Diagnostics Market by Application
12.3.8.5.3 South Korea Human Microbiome Based Drugs And Diagnostics Market by Disease
12.3.8.5.4 South Korea Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.3.8.5.5 South Korea Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.3.8.6 Rest of Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market
12.3.8.6.1 Rest of Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market by Product
12.3.8.6.2 Rest of Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market by Application
12.3.8.6.3 Rest of Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market by Disease
12.3.8.6.4 Rest of Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.3.8.6.5 Rest of Asia-Pacific Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market Overview
12.4.2 Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis
12.4.3 Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Product
12.4.4 Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Application
12.4.5 Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Disease
12.4.6 Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Research Spending, product Type
12.4.7 Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Research spending, Technology Type
12.4.8 Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Human Microbiome Based Drugs And Diagnostics Market
12.4.8.1.1 South Africa Human Microbiome Based Drugs And Diagnostics Market by Product
12.4.8.1.2 South Africa Human Microbiome Based Drugs And Diagnostics Market by Application
12.4.8.1.3 South Africa Human Microbiome Based Drugs And Diagnostics Market by Disease
12.4.8.1.4 South Africa Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.4.8.1.5 South Africa Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.4.8.2 Saudi Arabia Human Microbiome Based Drugs And Diagnostics Market
12.4.8.2.1 Saudi Arabia Human Microbiome Based Drugs And Diagnostics Market by Product
12.4.8.2.2 Saudi Arabia Human Microbiome Based Drugs And Diagnostics Market by Application
12.4.8.2.3 Saudi Arabia Human Microbiome Based Drugs And Diagnostics Market by Disease
12.4.8.2.4 Saudi Arabia Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.4.8.2.5 Saudi Arabia Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.4.8.3 U.A.E Human Microbiome Based Drugs And Diagnostics Market
12.4.8.3.1 U.A.E Human Microbiome Based Drugs And Diagnostics Market by Product
12.4.8.3.2 U.A.E Human Microbiome Based Drugs And Diagnostics Market by Application
12.4.8.3.3 U.A.E Human Microbiome Based Drugs And Diagnostics Market by Disease
12.4.8.3.4 U.A.E Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.4.8.3.5 U.A.E Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.4.8.4 Rest of Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market
12.4.8.4.1 Rest of Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market by Product
12.4.8.4.2 Rest of Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market by Application
12.4.8.4.3 Rest of Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market by Disease
12.4.8.4.4 Rest of Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.4.8.4.5 Rest of Middle East and Africa Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Human Microbiome Based Drugs And Diagnostics Market Overview
12.5.2 South and Central America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis
12.5.3 South and Central America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Product
12.5.4 South and Central America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Application
12.5.5 South and Central America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Disease
12.5.6 South and Central America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Research Spending, product Type
12.5.7 South and Central America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Research spending, Technology Type
12.5.8 South and Central America Human Microbiome Based Drugs And Diagnostics Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Human Microbiome Based Drugs And Diagnostics Market
12.5.8.1.1 Brazil Human Microbiome Based Drugs And Diagnostics Market by Product
12.5.8.1.2 Brazil Human Microbiome Based Drugs And Diagnostics Market by Application
12.5.8.1.3 Brazil Human Microbiome Based Drugs And Diagnostics Market by Disease
12.5.8.1.4 Brazil Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.5.8.1.5 Brazil Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.5.8.2 Argentina Human Microbiome Based Drugs And Diagnostics Market
12.5.8.2.1 Argentina Human Microbiome Based Drugs And Diagnostics Market by Product
12.5.8.2.2 Argentina Human Microbiome Based Drugs And Diagnostics Market by Application
12.5.8.2.3 Argentina Human Microbiome Based Drugs And Diagnostics Market by Disease
12.5.8.2.4 Argentina Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.5.8.2.5 Argentina Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
12.5.8.3 Rest of South and Central America Human Microbiome Based Drugs And Diagnostics Market
12.5.8.3.1 Rest of South and Central America Human Microbiome Based Drugs And Diagnostics Market by Product
12.5.8.3.2 Rest of South and Central America Human Microbiome Based Drugs And Diagnostics Market by Application
12.5.8.3.3 Rest of South and Central America Human Microbiome Based Drugs And Diagnostics Market by Disease
12.5.8.3.4 Rest of South and Central America Human Microbiome Based Drugs And Diagnostics Market by Research Spending, product Type
12.5.8.3.5 Rest of South and Central America Human Microbiome Based Drugs And Diagnostics Market by Research spending, Technology Type
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET, KEY COMPANY PROFILES
14.1. SECOND GENOME INC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ENTEROME BIOSCIENCE
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. YAKULT
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. DUPONT
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. VEDANTA BIOSCIENCES
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. METABIOMICS CORPORATION
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. VITHERA PHARMACEUTICALS
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. MICROBIOME THERAPEUTICS LLC
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. MERCK
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. OSEL
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS